Skip to main content
Top
Published in: Journal of Nuclear Cardiology 4/2020

01-08-2020 | Cardiac Amyloidosis | LETTER TO THE EDITOR

99mTc-labelled bone tracer myocardial quantification: About correlation with heart function

Authors: Cyrille Blondet, MD, Olivier Schaeffer, MD, Fabrice Hubelé, MD, Gérald-José Roul, MD, PhD, Alessio Imperiale, MD, PhD, Izzie Jacques Namer, MD, PhD

Published in: Journal of Nuclear Cardiology | Issue 4/2020

Login to get access

Excerpt

Amyloid Transthyretin Cardiac Amyloidosis (ATTR-CA) is one of the main causes of heart failure, especially in elderly population. Because of promising medical treatment like tafamidis, 99mTc-labelled bone tracer myocardial investigation provides the challenge of diagnosing and monitoring ATTR-CA patients.1 However, isotopic explorations reflect relative uptakes in tissues, here namely bone and myocardium. Furthermore, tissue tracer uptake mainly depends on kidney, liver and heart functions. As such, brain natriuretic peptide (BNP) is a widely used biomarker allowing follow-up of heart function. About 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) uptake in patients with Perugini 2 or 3 bone scan, we analyzed retrospectively 13 patients and quantified 2D myocardial uptake (planar H/WB ratio: myocardial uptake related to whole body; planar H/B ratio: myocardial uptake related to femoral diaphysis). There was a negative correlation (Spearman coefficient) between each ratio and BNP blood level: rs =  − 0.57, p = 0.045 (Figure 1: H/WB ratio) and rs =  − 0.61, p = 0.03 (Figure 2: H/B ratio). Such a statement should be expected but it questions isotopic quantification methods. Castano et al. showed that myocardial retention due to ATTR-CA might be of interesting prognostic importance.2 Hence, ATTR-CA monitoring treatment should need molecular imaging parameters, which provide data not only related to myocardial failure but more interestingly to disease progression, like probably summarized in 99mTc-labelled bone tracer myocardial quantification. This index might be corrected by the state of cardiac neuro-humoral adaptation, usually assessed by BNP, for specifically emphasizing information due to pathophysiological stage of ATTR-CA. Of course, this biological caution should not make forget to go on improving uptake quantification accuracy. Indeed, Manrique et al. recently demonstrated that 3D semi-quantitative analysis of CZT SPECT optimizes heart to background uptake ratio.3 As usual in nuclear medicine, both physical and biological considerations should improve imaging performance.
Literature
1.
go back to reference Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, et al. SNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. J Nucl Cardiol 2019;26:2065-2123CrossRef Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, et al. SNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. J Nucl Cardiol 2019;26:2065-2123CrossRef
2.
go back to reference Castano A, Haq M, Narotsky DL, Goldsmith J, Weinberg RL, Morgenstern R et al. Multicenter study of planar technetium 99 m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis. JAMA Cardiol 2016;1:880-889CrossRef Castano A, Haq M, Narotsky DL, Goldsmith J, Weinberg RL, Morgenstern R et al. Multicenter study of planar technetium 99 m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis. JAMA Cardiol 2016;1:880-889CrossRef
3.
go back to reference Manrique A, Dudoignon D, Brun S, N'Ganoa C, Cassol E, Legallois D, et al. Quantification of myocardial 99mTc-labeled bisphosphonate uptake with cadmium zinc telluride camera in patients with transthyretin-related cardiac amyloidosis. EJNMMI Res 2019;9:117CrossRef Manrique A, Dudoignon D, Brun S, N'Ganoa C, Cassol E, Legallois D, et al. Quantification of myocardial 99mTc-labeled bisphosphonate uptake with cadmium zinc telluride camera in patients with transthyretin-related cardiac amyloidosis. EJNMMI Res 2019;9:117CrossRef
Metadata
Title
99mTc-labelled bone tracer myocardial quantification: About correlation with heart function
Authors
Cyrille Blondet, MD
Olivier Schaeffer, MD
Fabrice Hubelé, MD
Gérald-José Roul, MD, PhD
Alessio Imperiale, MD, PhD
Izzie Jacques Namer, MD, PhD
Publication date
01-08-2020
Publisher
Springer International Publishing
Published in
Journal of Nuclear Cardiology / Issue 4/2020
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-020-02182-5

Other articles of this Issue 4/2020

Journal of Nuclear Cardiology 4/2020 Go to the issue